Cocaine disposition in meconium from newborns of cocaine-abusing mothers and urine of adult drug users

Journal of Analytical Toxicology

Volumn 20, Issue 6, 1996, Pages 453-462

  Oyler, Jonathan ^a   Darwin, William D ^a   Preston, Kenzie L ^a   Suess, Patricia ^a   Cone, Edward J ^a  

^a NIDA Addiction Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 HYDROXYBENZOYLECGONINE; 4 HYDROXYBENZOYLECGONINE; BENZOYLECGONINE; COCAINE; ECGONINE METHYL ESTER; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BLOOD CHEMISTRY; CLINICAL ARTICLE; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DRUG ABUSE; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MECONIUM ASPIRATION; PRENATAL DRUG EXPOSURE; PRENATAL EXPOSURE; URINALYSIS;

EID: 0029796376     PISSN: 01464760     EISSN: None     Source Type: Journal    
DOI: 10.1093/jat/20.6.453     Document Type: Article

References (42)

1. R.W. Foltin and M.W. Fischman. Ethanol and cocaine interactions in humans: cardiovascular consequences. Pharmacol. Biochem. Behav. 31: 877-83 (1988).
2. E.J. Cone. Pharmacokinetics and pharmacodynamics of cocaine. J. Anal. Toxicol. 19: 459-78 (1995).
3. C.W. Schindler. Cocaine and cardiovascular toxicity. Addict. Biol. 1: 31-47 (1996).
4. P. Jatlow, J.D. Elsworth, C.W. Bradberry, G. Winger, J.R. Taylor, R. Russell, and R.H. Roth. Cocaethylene: A neuropharmacologically active metabolite associated with concurrent cocaine-ethanol ingestion. Life Sci. 48: 1787-94 (1991).
5. W.L. Hearn, D.D. Flynn, G.W. Hime, S. Rose, J.C. Cofino, E. Mantero-Atienza, C.V. Wetli, and D.C. Mash. Cocaethylene: a unique cocaine metabolite displays high affinity for the dopamine transporter. J. Neurochem. 56: 698-701 (1991).
6. D.N. Bailey. Serial plama concentrations of cocaethylene, cocaine, and ethanol in trauma victims. J. Anal. Toxicol. 17: 79-83 (1993).
7. P. Jatlow. Cocaine: Analysis, pharmacokinetics, and metabolic disposition. Yale J. Biol. Med. 61: 105-13 (1988).
8. D.J. Stewart, T. Inaba, M. Lucassen, and W. Kalow. Cocaine metabolism: Cocaine and norcocaine hydrolysis by liver and serum esterases. Clin. Pharmacol. Ther. 25: 464-68 (1979).
9. T. Inaba, D.J. Stewart and W. Kalow. Metabolism of cocaine in man. Clin. Pharmacol. Ther. 23: 547-52 (1978).
10. J.Y. Zhang and R.L. Foltz. Cocaine metabolism in man: Identification of four previously unreported cocaine metabolites in human urine. J. Anal. Toxicol. 14: 201-205 (1990).
11. R.M. Smith. Arylhydroxy metabolites of cocaine in the urine of cocaine users. J. Anal. Toxicol. 8: 35-37 (1984).
12. B.W. Steele, E.S. Bandstra, N.-C. Wu, G.W. Hime, and W.L. Hearn. m-Hydroxybenzoylecgonine: An important contributor to the immunoreactivity in assays for benzoylecgonine in meconium. J. Anal. Toxicol. 17: 348-52 (1993).
13. D. Lewis, C. Moore, J. Becker, and J. Leikin. Prevalence of metahydroxybenzoylecgonine (M-OH-BZE) in meconium samples. In Proceedings of the 1994 Joint TIAFT/SOFT International Meeting. V. Spiehler, Ed., TIAFT/SOFT Joint Congress, Tampa, FL, 1994, pp 513-18.
14. G.M. Abusada, I.K. Abukhalaf, D.D. Alford, I. Vinzon-Bautista, A.K. Pramanik, N.A. Ansari, J.E. Manno, and B.R. Manno. Solid-phase extraction and GC/MS quantitation of cocaine, ecgonine methyl ester, benzoylecgonine, and cocaethylene from meconium, whole blood, and plasma. J. Anal. Toxicol. 17: 353-58 (1993).
15. D.E. Lewis, C.M. Moore, and J.B. Leikin. Cocaethylene in meconium specimens. Clin. Toxicol. 32: 697-703 (1994).
16. S. Browne, C. Moore, A. Negrusz, I. Tebbett, R. Covert, and A. Dusick. Detection of cocaine, norcocaine, and cocaethylene in the meconium of premature neonates. J. Forensic Sci. 39: 1515-19 (1994).
17. L.J. Murphey, G.D. Olsen, and R.J. Konkol. Quantitation of benzoylnorecgonine and other cocaine metabolites in meconium by high-performance liquid chromatography. J. Chromatogr. B. 613: 330-35 (1993).
18. B. Krauer and P. Dayer. Fetal drug metabolism and its possible clinical implications. Clin. Pharmacokinet. 21: 70-80 (1991).
19. Clean Screen Extraction Column: Applications Manual. Worldwide Monitioring Corporation, Horsham, PA, 1992, pp 1-42.
20. E.J. Cone, M. Hillsgrove, and W.D. Darwin. Simultaneous measurement of cocaine, cocaethylene, their metabolites, and "crack" pyrolysis products by gas chromatography-mass spectrometry. Clin. Chem. 40: 1299-1305 (1994).
21. C. Moore and A. Negrusz. Drugs of abuse in meconium. Forensic Sci. Rev. 7: 103-18 (1995).
22. E.M. Ostrea, M. Brady, S. Gause, A.L. Raymundo, and M. Stevens. Drug screening of newborns by meconium analysis: A large-scale, prospective, epidemiologic study. Pediatrics 89: 107-13 (1992).
23. E.M. Ostrea and R.A. Welch. Detection of prenatal drug exposure in the pregnant woman and her newborn infant. Clin. Perinatol. 18: 629-45 (1991).
24. T. Randall. Cocaine, alcohol mix in body to form even longer lasting, more lethal drug. J. Am. Med. Assoc. 267: 1043-44 (1992).
25. R.M. Ryan, C.L. Wagner, J.M. Schultz, J. Varley, J. DiPreta, D.M. Sherer, D.L. Phelps, and T. Kwong. Meconium analysis for improved identification of infants exposed to cocaine in utero. J. Pediatr. 125: 435-40 (1994).
26. S. Shulman Rosengren, D.B. Longobucco, B.A. Bernstein, S. Fishman, E. Cooke, F. Boctor, and S.C. Lewis. Meconium testing for cocaine metabolite: Prevalence, perceptions, and pitfalls. Am. J. Obstet. Gynecol. 168: 1449-56 (1993).
27. R.H. Schwartz and R.L. Hawks. Laboratory detection of marijuana use. J. Am. Med. Assoc. 254: 788-92 (1985).
28. N.L. Benowitz, J. Rosenberg, W. Rogers, J. Bachman, and R.T. Jones. Cardiovascular effects of intravenous delta-9-tetrahydrocannabinol: autonomic nervous mechanisms. Clin. Pharmacol. Ther. 25: 440-46 (1979).
29. J.A. Sandberg, L.J. Murphey, and G.D. Olsen. In vitro hepatic biotransformation of cocaine in maternal and fetal guinea pigs. Drug Metab. Dispos. 21: 390-95 (1993).
30. D.E. Lewis, C.M. Moore, J.B. Leikin, and A. Koller. Meconium analysis for cocaine: a validation study and comparison with paired urine analysis. J. Anal. Toxicol. 19: 148-50 (1995).
31. C.M. Callahan, T.M. Grant, P. Phipps, G. Clark, A.H. Novack, A.P. Streissguth, and V.A. Raisys. Measurement of gestational cocaine exposure: Sensitivity of infants' hair, meconium, and urine. J. Pediatr. 120: 763-68 (1992).
32. F. Moriya, K.-M. Chan, T.T. Noguchi, and P.Y.K. Wu. Testing for drugs of abuse in meconium of newborn infants. J. Anal. Toxicol. 18: 41-45 (1994).
33. E.M. Ostrea, A. Romero, and H. Yee. Adaption of the meconium drug test for mass screening. J. Pediatr. 122: 152-54 (1993).
34. W.E. Wingert, M.S. Feldman, M.H. Kim, L. Noble, I. Hand, and J.J. Yoon. A comparison of meconium, maternal urine and neonatal urine for detection of maternal drug use during pregnancy. J. Forensic Sci. 39: 150-58 (1994).
35. E.M. Ostrea, A. Romero, K. Knapp, A.R. Ostrea, J.E. Lucena, and R.B. Utarnachitt. Clinical and laboratory observations: post-mortem drug analysis of meconium in early-gestation human fetuses exposed to cocaine: clinical implications. J. Pediatr. 124: 477-79 (1994).
36. E.M. Ostrea, M.J. Brady, P.M. Parks, D.C. Asensio, and A. Naluz. Drug screening of meconium in infants of drug-dependent mothers: an alternative to urine testing. J. Pediatr. 115: 474-77 (1989).
37. N. Lombardero, O. Casanova, M. Behnke, F.D. Eyler, and R.L. Bertholf. Measurement of cocaine and metabolites in urine, meconium and diapers by gas chromatography/mass spectrometry. Ann. Clin. Lab. Sci. 23: 385-94 (1993).
38. D.G. May. Genetic differences in drug disposition. J. Clin. Pharmacol. 34: 881-97 (1994).
39. C.S. Boyer and D.R. Petersen. Enzymatic basis for the transesterification of cocaine in the presence of ethanol: evidence for the participation of microsomal carboxylesterases. J. Pharmacol. Exp. Ther. 260: 939-46 (1992).
40. W.L. Hearn, S. Rose, J. Wagner, A. Ciarleglio, and D.C. Mash. Cocaethylene is more potent than cocaine in mediating lethality. Pharmacol. Biochem. Behav. 39: 531-33 (1991).
41. J.L. Katz, P. Terry, and J.M. Witkin. Comparative behavioral pharmacology and toxicology of cocaine and its ethanol-derived metabolite, cocaine ethyl-ester (cocaethylene). Life Sci. 50: 1351-61 (1992).
42. Diagnostic and Statistical Manual of Mental Disorders, DSM-III-R, 3rd ed. American Psychiatric Association, Washington, DC, 1987.